Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: J Dev Behav Pediatr. 2009 Apr;30(2):131–139. doi: 10.1097/DBP.0b013e31819e6a48

Table 1.

Baseline Characteristics of Infants Randomized to Treatment Groups

Placebo N = 215 Iron/FA N = 223 Zinc N = 219 Combined Tx N = 220
Pemba Island, Zanzibar
 Age (mo) 12.1 ± 3.8a 12.4 ± 4.0 12.9 ± 3.9 12.7 ± 4.2
 Percent girls 49.8 48.0 53.0 45.0
 Hbb 9.5 ± 1.6 9.2 ± 1.5 9.6 ± 1.5 9.4 ± 1.5
 Percent w/Hb <10b 57.3 63.3 53.9c 59.5
 Percent w/ZPP ≥90d 80.7 79.1 72.2e 73.0
 Percent IDA 53.3 58.2 44.8c 52.5
 Percent stunted 36.7 36.6 31.6 32.7
 Percent wasted 4.2 4.5 4.6 7.7
 Percent underweight 34.1 32.7 29.4 31.8
N = 152 N = 129 N = 125 N = 161

Sarlahi District, Nepal
 Age (mo) 11.2 ± 4.1 10.6 ± 3.7 10.4 ± 4.2 10.9 ± 4.1
 Percent girls 53.9 45.0 58.4 44.1f
 Hbb 9.9 ± 1.2 10.0 ± 1.1 10.7 ± 1.2c,e,g 10.1 ± 1.3
 Percent w/Hb <10b 48.6 40.6 20.5c,e,g 43.4
 Percent w/ZPP ≥90c 60.3 68.3 39.0c,e,g 63.2
 Percent IDA 36.8 35.8 12.3c,e,g 35.5
 Percent stunted 43.1 29.3e 25.6e 34.4
 Percent wasted 21.2 20.3 26.9 25.6
 Percent underweight 58.2 49.6 44.9 52.9
 Low-caste Hindu 64.4 85.9 80.7c,e 77.4
 Muslim 32.2 9.3e 7.2e,g 16.1e

IDA, iron deficiency anemia; ZPP, zinc protoporphyrin; FA, folic acid.

a

Values shown as mean ±SD.

b

Units given in g/dL.

c

Different from iron–folic acid.

d

Units given in μmol ZPP/mol heme.

e

Different from placebo.

f

Different from zinc.

g

Different from the combined treatment, all p < .05.